Cancer Drug Development

Drug Development is the lengthy procedure because it has ability new drug must be identified and assessed in preclinical and clinical trials. Drug development medication can happen some different ways. If scientist identify new drug by examine numerous compounds in a laboratory procedure for effective ways, like killing or destroying cancerous cells. Cancer drug development is to target DNA or protein. Currently researchers are looking for whole new set of targets. Development of anti-cancer drug is evolving a step towards the invention of novel therapeutics.

Current concept of understanding the kind of cancer invent to conceptual drug design, in which new substance is developed to target a specific disease procedure. At a time, factual medication are found to be having an effectual effect against a various type of cancerous cells. New discovery lead to alteration in designs how medication reach cancerous cells present among the body, thus leading to the capacity to develop a substance. At starting procedure is referred to target and lead identification, validation, and optimization.


  • Tumour Targeting Strategies
  • Hormonal & Biological Agents
  • Cancer Drug Targets
  • Anti-cancer drugs

Related Conference of Cancer Drug Development

April 17-18, 2024

14th International Conference on Chemistry Meeting

Paris, France
June 25-26, 2024

13th World Congress on Chromatography

Toronto, Canada
August 22-23, 2024

16th International Conference on Clinical Chemistry

Berlin, Germany
December 18-19, 2024

4th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands

Cancer Drug Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in